Cargando…
Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day()
BACKGROUND: Leprosy can have its course interrupted by type 1 and 2 reactional episodes, the last named of erythema nodosum leprosum (ENL). Thalidomide has been the medication of choice for the control of ENL episodes since 1965. OBJECTIVES: These episodes can repeat and cause damages to the patient...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Dermatologia
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008057/ https://www.ncbi.nlm.nih.gov/pubmed/24770503 http://dx.doi.org/10.1590/abd1806-4841.20142037 |